Download PDF
Semin Thromb Hemost 2009; 35(2): 213-223
DOI: 10.1055/s-0029-1220329
© Thieme Medical Publishers

Role of Platelet Electron Microscopy in the Diagnosis of Platelet Disorders

Sylvain Clauser1 , Elisabeth Cramer-Bordé2
  • 1Service d'Hématologie-Immunologie, Hôpital Ambroise Paré, Assistance Publique-Hôpitaux de Paris, Boulogne, Université de Versailles, Saint Quentin en Yvelines, France
  • 2INSERM U567, Département d'Hématologie, Institut Cochin, Maternité Port Royal, Paris, France
Further Information

Publication History

Publication Date:
30 April 2009 (online)

    Permissions and Reprints

ABSTRACT

The electron microscope has proved to be a useful tool to study and understand the biology of platelets and to classify many platelet disorders. After a technical overview, this article reviews syndromes originating from platelet organelle, cytoskeleton, and membrane defects for which electron microscopy plays a role in the diagnostic process, such as gray platelet syndrome, Paris-Trousseau syndrome, storage pool diseases, MYH9-related thrombocytopenias, or Wiskott-Aldrich syndrome. Particular focus is given to the ultrastructural aspect of platelets in these disorders.

KEYWORDS

Platelet - electron - microscopy - diagnosis

REFERENCES

  • 1 Balduini C L, Cattaneo M, Fabris F Italian Gruppo di Studio delle Piastrine et al. Inherited thrombocytopenias: a proposed diagnostic algorithm from the Italian Gruppo di Studio delle Piastrine.  Haematologica. 2003;  88 582-592
    PubMedGoogle Scholar
  • 2 Raccuglia G. Gray platelet syndrome. A variety of qualitative platelet disorder.  Am J Med. 1971;  51 818-828
    CrossrefPubMedGoogle Scholar
  • 3 Jantunen E, Hänninen A, Naukkarinen A, Vornanen M, Lahtinen R. Gray platelet syndrome with splenomegaly and signs of extramedullary hematopoiesis: a case report with review of the literature.  Am J Hematol. 1994;  46 218-224
    PubMedGoogle Scholar
  • 4 Köhler M, Hellstern P, Morgenstern E et al.. Gray platelet syndrome: selective alpha-granule deficiency and thrombocytopenia due to increased platelet turnover.  Blut. 1985;  50 331-340
    PubMedGoogle Scholar
  • 5 Martínez-Murillo C, Payns Borrego E, Arzate Hernández G et al.. [Gray-platelet syndrome associated with Marfan disease in a Mexican family].  Sangre (Barc). 1994;  39 287-291
    PubMedGoogle Scholar
  • 6 Drouin A, Favier R, Massé J M et al.. Newly recognized cellular abnormalities in the gray platelet syndrome.  Blood. 2001;  98 1382-1391
    CrossrefPubMedGoogle Scholar
  • 7 White J G. Ultrastructural studies of the gray platelet syndrome.  Am J Pathol. 1979;  95 445-462
    PubMedGoogle Scholar
  • 8 Levy-Toledano S, Caen J P, Breton-Gorius J et al.. Gray platelet syndrome: alpha-granule deficiency. Its influence on platelet function.  J Lab Clin Med. 1981;  98 831-848
    PubMedGoogle Scholar
  • 9 Gerrard J M, Phillips D R, Rao G H et al.. Biochemical studies of two patients with the gray platelet syndrome. Selective deficiency of platelet alpha granules.  J Clin Invest. 1980;  66 102-109
    CrossrefPubMedGoogle Scholar
  • 10 Nurden A T, Kunicki T J, Dupuis D, Soria C, Caen J P. Specific protein and glycoprotein deficiencies in platelets isolated from two patients with the gray platelet syndrome.  Blood. 1982;  59 709-718
    PubMedGoogle Scholar
  • 11 Breton-Gorius J, Vainchenker W, Nurden A, Levy-Toledano S, Caen J. Defective alpha-granule production in megakaryocytes from gray platelet syndrome: ultrastructural studies of bone marrow cells and megakaryocytes growing in culture from blood precursors.  Am J Pathol. 1981;  102 10-19
    PubMedGoogle Scholar
  • 12 Cramer E M, Vainchenker W, Vinci G, Guichard J, Breton-Gorius J. Gray platelet syndrome: immunoelectron microscopic localization of fibrinogen and von Willebrand factor in platelets and megakaryocytes.  Blood. 1985;  66 1309-1316
    PubMedGoogle Scholar
  • 13 Rosa J P, George J N, Bainton D F, Nurden A T, Caen J P, McEver R P. Gray platelet syndrome. Demonstration of alpha granule membranes that can fuse with the cell surface.  J Clin Invest. 1987;  80 1138-1146
    CrossrefPubMedGoogle Scholar
  • 14 Favier R, Douay L, Esteva B et al.. A novel genetic thrombocytopenia (Paris-Trousseau) associated with platelet inclusions, dysmegakaryopoiesis and chromosome deletion AT 11q23.  C R Acad Sci III. 1993;  316 698-701
    PubMedGoogle Scholar
  • 15 Breton-Gorius J, Favier R, Guichard J et al.. A new congenital dysmegakaryopoietic thrombocytopenia (Paris-Trousseau) associated with giant platelet alpha-granules and chromosome 11 deletion at 11q23.  Blood. 1995;  85 1805-1814
    PubMedGoogle Scholar
  • 16 Krishnamurti L, Neglia J P, Nagarajan R et al.. Paris-Trousseau syndrome platelets in a child with Jacobsen's syndrome.  Am J Hematol. 2001;  66 295-299
    CrossrefPubMedGoogle Scholar
  • 17 Pivnick E K, Velagaleti G V, Wilroy R S et al.. Jacobsen syndrome: report of a patient with severe eye anomalies, growth hormone deficiency, and hypothyroidism associated with deletion 11 (q23q25) and review of 52 cases.  J Med Genet. 1996;  33 772-778
    CrossrefPubMedGoogle Scholar
  • 18 Grossfeld P D, Mattina T, Lai Z et al.. The 11q terminal deletion disorder: a prospective study of 110 cases.  Am J Med Genet A. 2004;  129A 51-61
    CrossrefPubMedGoogle Scholar
  • 19 Hayward C P, Rivard G E, Kane W H et al.. An autosomal dominant, qualitative platelet disorder associated with multimerin deficiency, abnormalities in platelet factor V, thrombospondin, von Willebrand factor, and fibrinogen and an epinephrine aggregation defect.  Blood. 1996;  87 4967-4978
    PubMedGoogle Scholar
  • 20 Kahr W H, Zheng S, Sheth P M et al.. Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator.  Blood. 2001;  98 257-265
    CrossrefPubMedGoogle Scholar
  • 21 Tracy P B, Giles A R, Mann K G, Eide L L, Hoogendoorn H, Rivard G E. Factor V (Quebec): a bleeding diathesis associated with a qualitative platelet factor V deficiency.  J Clin Invest. 1984;  74 1221-1228
    CrossrefPubMedGoogle Scholar
  • 22 Hayward C P, Bainton D F, Smith J W et al.. Multimerin is found in the alpha-granules of resting platelets and is synthesized by a megakaryocytic cell line.  J Clin Invest. 1993;  91 2630-2639
    CrossrefPubMedGoogle Scholar
  • 23 Hayward C P, Cramer E M, Kane W H et al.. Studies of a second family with the Quebec platelet disorder: evidence that the degradation of the alpha-granule membrane and its soluble contents are not secondary to a defect in targeting proteins to alpha-granules.  Blood. 1997;  89 1243-1253
    CrossrefPubMedGoogle Scholar
  • 24 Veljkovic D K, Rivard G E, Diamandis M, Blavignac J, Cramer-Borde E M, Hayward C P. Increased expression of urokinase plasminogen activator in Quebec platelet disorder is linked to megakaryocyte differentiation.  Blood. 2009;  113 1535-1542
    CrossrefPubMedGoogle Scholar
  • 25 Diamandis M, Paterson A D, Rommens J M et al.. Quebec platelet disorder is linked to the urokinase plasminogen activator gene (PLAU) and increases expression of the linked allele in megakaryocytes.  Blood. 2009;  113 1543-1546
    CrossrefPubMedGoogle Scholar
  • 26 Nieuwenhuis H K, Akkerman J W, Sixma J J. Patients with a prolonged bleeding time and normal aggregation tests may have storage pool deficiency: studies on one hundred six patients.  Blood. 1987;  70 620-623
    PubMedGoogle Scholar
  • 27 Holmsen H, Weiss H J. Hereditary defect in the platelet release reaction caused by a deficiency in the storage pool of platelet adenine nucleotides.  Br J Haematol. 1970;  19 643-649
    PubMedGoogle Scholar
  • 28 Holmsen H, Weiss H J. Further evidence for a deficient storage pool of adenine nucleotides in platelets from some patients with thrombocytopathia—“storage pool disease”.  Blood. 1972;  39 197-209
    PubMedGoogle Scholar
  • 29 Lages B, Scrutton M C, Holmsen H, Day H J, Weiss H J. Metal ion contents of gel-filtered platelets from patients with storage pool disease.  Blood. 1975;  46 119-130
    PubMedGoogle Scholar
  • 30 Weiss H J, Witte L D, Kaplan K L et al.. Heterogeneity in storage pool deficiency: studies on granule-bound substances in 18 patients including variants deficient in alpha-granules, platelet factor 4, beta-thromboglobulin, and platelet-derived growth factor.  Blood. 1979;  54 1296-1319
    PubMedGoogle Scholar
  • 31 Israels S J, McNicol A, Robertson C, Gerrard J M. Platelet storage pool deficiency: diagnosis in patients with prolonged bleeding times and normal platelet aggregation.  Br J Haematol. 1990;  75 118-121
    PubMedGoogle Scholar
  • 32 Weiss H J, Ames R P. Ultrastructural findings in storage pool disease and aspirin-like defects of platelets.  Am J Pathol. 1973;  71 447-466
    PubMedGoogle Scholar
  • 33 McNicol A, Israels S J, Robertson C, Gerrard J M. The empty sack syndrome: a platelet storage pool deficiency associated with empty dense granules.  Br J Haematol. 1994;  86 574-582
    CrossrefPubMedGoogle Scholar
  • 34 Hermansky F, Pudlak P. Albinism associated with hemorrhagic diathesis and unusual pigmented reticular cells in the bone marrow: report of two cases with histochemical studies.  Blood. 1959;  14 162-169
    PubMedGoogle Scholar
  • 35 Di Pietro S M, Falcón-Pérez J M, Tenza D et al.. BLOC-1 interacts with BLOC-2 and the AP-3 complex to facilitate protein trafficking on endosomes.  Mol Biol Cell. 2006;  17 4027-4038
    CrossrefPubMedGoogle Scholar
  • 36 Hardisty R M, Hutton R A. Bleeding tendency associated with “new” abnormality of platelet behaviour.  Lancet. 1967;  1 983-985
    PubMedGoogle Scholar
  • 37 Maurer H M, Wolff J A, Buckingham S, Spielvogel A R. “Impotent” platelets in albinos with prolonged bleeding times.  Blood. 1972;  39 490-499
    PubMedGoogle Scholar
  • 38 White J G, Edson J R, Desnick S J, Witkop Jr C J. Studies of platelets in a variant of the Hermansky-Pudlak syndrome.  Am J Pathol. 1971;  63 319-332
    PubMedGoogle Scholar
  • 39 Witkop C J, Krumwiede M, Sedano H, White J G. Reliability of absent platelet dense bodies as a diagnostic criterion for Hermansky-Pudlak syndrome.  Am J Hematol. 1987;  26 305-311
    PubMedGoogle Scholar
  • 40 Chediak M M. [New leukocyte anomaly of constitutional and familial character].  Rev Hematol. 1952;  7 362-367
    PubMedGoogle Scholar
  • 41 Higashi O. Congenital gigantism of peroxidase granules; the first case ever reported of qualitative abnormity of peroxidase.  Tohoku J Exp Med. 1954;  59 315-332
    PubMedGoogle Scholar
  • 42 Sato A. Chédiak and Higashi's disease: probable identity of a new leucocytal anomaly (Chédiak) and congenital gigantism of peroxidase granules (Higashi).  Tohoku J Exp Med. 1955;  61 201-210
    PubMedGoogle Scholar
  • 43 Introne W, Boissy R E, Gahl W A. Clinical, molecular, and cell biological aspects of Chediak-Higashi syndrome.  Mol Genet Metab. 1999;  68 283-303
    CrossrefPubMedGoogle Scholar
  • 44 White J G. The Chediak-Higashi syndrome: a possible lysosomal disease.  Blood. 1966;  28 143-156
    PubMedGoogle Scholar
  • 45 Apitz-Castro R, Cruz M R, Ledezma E et al.. The storage pool deficiency in platelets from humans with the Chédiak-Higashi syndrome: study of six patients.  Br J Haematol. 1985;  59 471-483
    PubMedGoogle Scholar
  • 46 Rendu F, Breton-Gorius J, Lebret M et al.. Evidence that abnormal platelet functions in human Chédiak-Higashi syndrome are the result of a lack of dense bodies.  Am J Pathol. 1983;  111 307-314
    PubMedGoogle Scholar
  • 47 White J G. Platelet microtubules and giant granules in the Chediak-Higashi syndrome.  Am J Med Technol. 1978;  44 273-278
    PubMedGoogle Scholar
  • 48 Althaus K, Greinacher A. MYH9-related platelet disorders.  Semin Thromb Hemost. 2009;  35 189-203
    Article in Thieme ConnectPubMedGoogle Scholar
  • 49 May R. Leukozyteneinschlüsse.  Deutsch Arch Klin Med. 1909;  96 1-6
    PubMedGoogle Scholar
  • 50 Hegglin R. Gleichzeitige konstitutionelle veränderungen an neutrophilen und thrombozyten.  Helvet Med Acta-Series A. 1945;  4/5 439-440
    PubMedGoogle Scholar
  • 51 Jordan S W, Larsen W E. Ultrastructural studies of the May-Hegglin anomaly.  Blood. 1965;  25 921-932
    PubMedGoogle Scholar
  • 52 Peterson L C, Rao K V, Crosson J T, White J G. Fechtner syndrome—a variant of Alport's syndrome with leukocyte inclusions and macrothrombocytopenia.  Blood. 1985;  65 397-406
    PubMedGoogle Scholar
  • 53 Greinacher A, Nieuwenhuis H K, White J G. Sebastian platelet syndrome: a new variant of hereditary macrothrombocytopenia with leukocyte inclusions.  Blut. 1990;  61 282-288
    CrossrefPubMedGoogle Scholar
  • 54 Seri M, Cusano R, Gangarossa S The May-Heggllin/Fechtner Syndrome Consortium et al. Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes.  Nat Genet. 2000;  26 103-105
    CrossrefPubMedGoogle Scholar
  • 55 Seri M, Savino M, Bordo D et al.. Epstein syndrome: another renal disorder with mutations in the nonmuscle myosin heavy chain 9 gene.  Hum Genet. 2002;  110 182-186
    PubMedGoogle Scholar
  • 56 Seri M, Pecci A, Di Bari F et al.. MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness.  Medicine (Baltimore). 2003;  82 203-215
    CrossrefPubMedGoogle Scholar
  • 57 Deutsch S, Rideau A, Bochaton-Piallat M L et al.. Asp1424Asn MYH9 mutation results in an unstable protein responsible for the phenotypes in May-Hegglin anomaly/Fechtner syndrome.  Blood. 2003;  102 529-534
    CrossrefPubMedGoogle Scholar
  • 58 Marigo V, Nigro A, Pecci A et al.. Correlation between the clinical phenotype of MYH9-related disease and tissue distribution of class II nonmuscle myosin heavy chains.  Genomics. 2004;  83 1125-1133
    CrossrefPubMedGoogle Scholar
  • 59 Lusher J M, Schneider J, Mizukami I, Evans R K. The May-Hegglin anomaly: platelet function, ultrastructure and chromosome studies.  Blood. 1968;  32 950-961
    PubMedGoogle Scholar
  • 60 Volpe E, Cuccurullo L, Valente A, Jori G P, Buonanno G. The May-Hegglin anomaly. Further studies on leukocyte inclusions and platelet ultrastructure.  Acta Haematol. 1974;  52 238-247
    CrossrefPubMedGoogle Scholar
  • 61 White J G, Sauk J J. The organization of microtubules and microtubule coils in giant platelet disorders.  Am J Pathol. 1984;  116 514-522
    PubMedGoogle Scholar
  • 62 Noris P, Spedini P, Belletti S, Magrini U, Balduini C L. Thrombocytopenia, giant platelets, and leukocyte inclusion bodies (May-Hegglin anomaly): clinical and laboratory findings.  Am J Med. 1998;  104 355-360
    PubMedGoogle Scholar
  • 63 Pujol-Moix N, Kelley M J, Hernández A, Muñiz-Diaz E, Español I. Ultrastructural analysis of granulocyte inclusions in genetically confirmed MYH9-related disorders.  Haematologica. 2004;  89 330-337
    PubMedGoogle Scholar
  • 64 Notarangelo L D, Miao C H, Ochs H D. Wiskott-Aldrich syndrome.  Curr Opin Hematol. 2008;  15 30-36
    CrossrefPubMedGoogle Scholar
  • 65 Bosticardo M, Marangoni F, Aiuti A, Villa A, Roncarolo M G. Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome.  Blood. 2009;  , April 7 (Epub ahead of print)
    PubMedGoogle Scholar
  • 66 Derry J M, Ochs H D, Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome.  Cell. 1994;  78 635-644
    CrossrefPubMedGoogle Scholar
  • 67 Villa A, Notarangelo L, Macchi P et al.. X-linked thrombocytopenia and Wiskott-Aldrich syndrome are allelic diseases with mutations in the WASP gene.  Nat Genet. 1995;  9 414-417
    PubMedGoogle Scholar
  • 68 Symons M, Derry J M, Karlak B et al.. Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization.  Cell. 1996;  84 723-734
    CrossrefPubMedGoogle Scholar
  • 69 Gröttum K A, Hovig T, Holmsen H, Abrahamsen A F, Jeremic M, Seip M. Wiskott-Aldrich syndrome: qualitative platelet defects and short platelet survival.  Br J Haematol. 1969;  17 373-388
    PubMedGoogle Scholar
  • 70 Baldini M G. Nature of the platelet defect in the Wiskott-Aldrich syndrome.  Ann N Y Acad Sci. 1972;  201 437-444
    PubMedGoogle Scholar
  • 71 Marone G, Albini F, di Martino L, Quattrin S, Poto S, Condorelli M. The Wiskott-Aldrich syndrome: studies of platelets, basophils and polymorphonuclear leucocytes.  Br J Haematol. 1986;  62 737-745
    CrossrefPubMedGoogle Scholar
  • 72 Haddad E, Cramer E, Rivière C et al.. The thrombocytopenia of Wiskott Aldrich syndrome is not related to a defect in proplatelet formation.  Blood. 1999;  94 509-518
    PubMedGoogle Scholar
  • 73 Dixon R E, Davis W E, Benbow J B, Kremer W B. Spherical platelet syndrome: absent microtubules and a bleeding diathesis.  Clin Res. 1974;  22 388A
    PubMedGoogle Scholar
  • 74 Schneider W, Morgenstern E, Reimers H J. Disassembly of microtubules in the Lesch-Nyhan syndrome? (Lesch-Nyhan syndrome and microtubules).  Klin Wochenschr. 1979;  57 181-186
    CrossrefPubMedGoogle Scholar
  • 75 White J G, de Alarcon P A. Platelet spherocytosis: a new bleeding disorder.  Am J Hematol. 2002;  70 158-166
    CrossrefPubMedGoogle Scholar
  • 76 Bernard J, Soulier J P. Sur une nouvelle variété de dystrophie thrombocytaire-hémorragipare congénitale.  Sem Hop Paris. 1948;  24 3217-3223
    PubMedGoogle Scholar
  • 77 López J A, Andrews R K, Afshar-Kharghan V, Berndt M C. Bernard-Soulier syndrome.  Blood. 1998;  91 4397-4418
    PubMedGoogle Scholar
  • 78 De Marco L, Mazzucato M, Fabris F et al.. Variant Bernard-Soulier syndrome type bolzano. A congenital bleeding disorder due to a structural and functional abnormality of the platelet glycoprotein Ib-IX complex.  J Clin Invest. 1990;  86 25-31
    CrossrefPubMedGoogle Scholar
  • 79 Smith T P, Dodds W J, Tartaglia A P. Thrombasthenic-thrombopathic thrombocytopenia with giant, “Swiss-cheese” platelets. A case report.  Ann Intern Med. 1973;  79 828-834
    PubMedGoogle Scholar
  • 80 Maldonado J E, Gilchrist G S, Brigden L P, Bowie E J. Ultrastructure of platelets in Bernard-Soulier syndrome.  Mayo Clin Proc. 1975;  50 402-406
    PubMedGoogle Scholar
  • 81 White J G, Gerrard J M. Ultrastructural features of abnormal blood platelets. A review.  Am J Pathol. 1976;  83 589-632
    PubMedGoogle Scholar
  • 82 Hourdillé P, Pico M, Jandrot-Perrus M, Lacaze D, Lozano M, Nurden A T. Studies on the megakaryocytes of a patient with the Bernard-Soulier syndrome.  Br J Haematol. 1990;  76 521-530
    CrossrefPubMedGoogle Scholar
  • 83 Ware J, Russell S, Ruggeri Z M. Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome.  Proc Natl Acad Sci U S A. 2000;  97 2803-2808
    CrossrefPubMedGoogle Scholar
  • 84 Cunningham J G, Meyer S C, Fox J E. The cytoplasmic domain of the alpha-subunit of glycoprotein (GP) Ib mediates attachment of the entire GP Ib-IX complex to the cytoskeleton and regulates von Willebrand factor-induced changes in cell morphology.  J Biol Chem. 1996;  271 11581-11587
    CrossrefPubMedGoogle Scholar
  • 85 Behrens W E. Mediterranean macrothrombocytopenia.  Blood. 1975;  46 199-208
    PubMedGoogle Scholar
  • 86 Savoia A, Balduini C L, Savino M et al.. Autosomal dominant macrothrombocytopenia in Italy is most frequently a type of heterozygous Bernard-Soulier syndrome.  Blood. 2001;  97 1330-1335
    CrossrefPubMedGoogle Scholar
  • 87 Kobrynski L J, Sullivan K E. Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes.  Lancet. 2007;  370 1443-1452
    CrossrefPubMedGoogle Scholar
  • 88 Liang H P, Morel-Kopp M C, Curtin J et al.. Heterozygous loss of platelet glycoprotein (GP) Ib-V-IX variably affects platelet function in velocardiofacial syndrome (VCFS) patients.  Thromb Haemost. 2007;  98 1298-1308
    Article in Thieme ConnectPubMedGoogle Scholar
  • 89 Budarf M L, Konkle B A, Ludlow L B et al.. Identification of a patient with Bernard-Soulier syndrome and a deletion in the DiGeorge/velo-cardio-facial chromosomal region in 22q11.2  Hum Mol Genet. 1995;  4 763-766
    CrossrefPubMedGoogle Scholar
  • 90 Richards J G, Da Prada M. Uranaffin reaction: a new cytochemical technique for the localization of adenine nucleotides in organelles storing biogenic amines.  J Histochem Cytochem. 1977;  25 1322-1326
    PubMedGoogle Scholar

Pr. Elisabeth Cramer-Bordé

Service d'Hématologie-Immunologie, Hôpital Ambroise Paré

9, avenue Charles de Gaulle, 92104 Boulogne-Billancourt, France

Email: elisabeth.borde@apr.aphp.fr

      >